MEDINDIA

Search Medindia

Cigarette Carcinogens: Manufacturing Companies Face Failure in Sustaining Reduction

by Madhumathi Palaniappan on Jun 9 2017 5:49 PM

Cigarette manufacturing companies could face failure in sustaining reduction of carcinogens like Tobacco-specific nitrosamines.

Cigarette Carcinogens: Manufacturing Companies Face Failure in Sustaining Reduction
Cigarettes contain tobacco and causes cancer. Tobacco-specific nitrosamines (TSNAs) are potent carcinogens that are formed during the cigarette manufacturing process.
Inspite of reducing the TSNA levels in cigarettes sold in Canada by the Ontario government to manufacture in 2000. A recent study published in the journal Nicotine & Tobacco Research had found that the decrease in TSNAs cannot not been sustained.

TOP INSIGHT

Did You Know

Tobacco-specific nitrosamines are potent carcinogens in cigarettes. Manufacturing companies face failure in sustaining the reduction.

The authors reviewed TSNA levels in unburned tobacco and in tobacco smoke from cigarettes produced by manufacturers that constitute 90% of Canada's cigarette market.

Following initial reductions, TSNA levels in cigarettes sold in Canada consistently increased after 2007. By 2012, the levels were 2 to 40 times higher than those observed in 2007.

Though TSNA levels at the end of the study period were still below those before government subsidies, the increases raise several important issues. "Overall, the findings indicate alarming increases in the TSNA levels of cigarettes sold in Canada," says co-author Dr. David Hammond, researcher at the School of Public Health & Health Systems at the University of Waterloo.

While the increases in TSNAs should not be interpreted as a direct increase in health risk, Hammond says "manufacturers bear a responsibility to minimize consumer exposure to potent carcinogens to the fullest extent possible. The failure to sustain these reductions signifies a lack of commitment towards harm reduction."



Source-Eurekalert



⬆️